Grant: Op Grant: Analyses of Existing Canadian Cohorts & Databases - Cancer Control
McGill University
$75,000.00
Levels of serum Arresten as a risk factor for the development and progression of high fatality cancers.
EF 2016-17
Résumé
The p53 tumour suppressor protein is the main factor that protects humans from cancer. The gene that encodes p53 is the most frequently mutated gene in all cancers. Dr. Teodoro is studying a natural inhibitor of tumour growth that is regulated by p53 called Arresten. Research from the Teodoro lab suggests that the abundance of Arresten in the blood may determine the predisposition of individuals to develop pancreatic cancer. Dr. Teodoro's research group have recently developed a simple blood test to measure levels of Arresten and have found that Arresten levels are lower in the blood of lung cancer patients. In this proposal they will study how p53 regulates Arresten levels and if we can manipulate Arresten as a cancer diagnostic or therapy.
Programme
Op Grant: Analyses of Existing Canadian Cohorts & Databases - Cancer Control
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
363278
Name
Teodoro Jose G
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Analyses of existing Canadian cohorts and databases related to Cancer
Projecttitle
Levels of serum Arresten as a risk factor for the development and progression of high fatality cancers.
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
Op Grant: Analyses of Existing Canadian Cohorts & Databases - Cancer Control
Keyworddelim
Anti-Angiogenic Factors; Arresten; Biomarkers; Cancer Risk Factors; Elisa; Lung Cancer; P53; Pancreatic Cancer; Serum Proteins; Tumor Suppressors
Abstract
The p53 tumour suppressor protein is the main factor that protects humans from cancer. The gene that encodes p53 is the most frequently mutated gene in all cancers. Dr. Teodoro is studying a natural inhibitor of tumour growth that is regulated by p53 called Arresten. Research from the Teodoro lab suggests that the abundance of Arresten in the blood may determine the predisposition of individuals to develop pancreatic cancer. Dr. Teodoro's research group have recently developed a simple blood test to measure levels of Arresten and have found that Arresten levels are lower in the blood of lung cancer patients. In this proposal they will study how p53 regulates Arresten levels and if we can manipulate Arresten as a cancer diagnostic or therapy.
Competitiondate
201609
Approvedterm2
1 yr 0 mth
Pinamesdelim
Teodoro, Jose G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $75,000~ $0~